Label free imaging of blood smears and tissue biopsies

血涂片和组织活检的无标记成像

基本信息

项目摘要

DESCRIPTION (provided by applicant): This exploratory project is aimed at investigating the potential of newly developed optical interferometric technique that we developed- Spatial Light Interference Microscopy (SLIM)-- for characterizing blood smears and tissue biopsies. SLIM is label-free and uniquely sensitive to refractive index modifications brought to the biospecimen by disease development . If successful, in the long-run, i.e. 5-10 years period, we anticipate that this label-free approach to imaging biospecimens will provide faster access to clinically-relevant data, as it bypasses most of the histology preparation process, e.g. staining. Further, due to its exquisite sensitivity to structural changes in the tissue, SLIM will provide a greater wealth of information than common histology, which should aid the pathologist in reaching a faster, more accurate diagnosis. The exploratory stage project will have the following specific aims: develop advanced, high-throughput instrumentation, perform proof-of principle studies on blood smears with focus on several specific diseases, and image biopsies of normal and three types of cancers (breast, prostate, and lung).
描述(由申请人提供):该探索性项目旨在研究我们开发的新开发的光学干涉技术-空间光干涉显微镜(SLIM)-用于表征血液涂片和组织活检的潜力。SLIM是无标记的,对疾病发展给生物样本带来的折射率变化非常敏感。如果成功的话,从长远来看,即5-10年的时间,我们预计这种无标记的生物样本成像方法将提供更快的临床相关数据,因为它绕过了大部分组织学制备过程,例如染色。此外,由于其对组织结构变化的敏感性,SLIM将提供比普通组织学更丰富的信息,这将有助于病理学家更快,更准确地诊断。探索阶段项目将有以下具体目标:开发先进的高通量仪器,对血液涂片进行原理验证研究,重点关注几种特定疾病,并对正常和三种类型的癌症(乳腺癌,前列腺癌和肺癌)进行图像活检。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gabriel Popescu其他文献

Gabriel Popescu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gabriel Popescu', 18)}}的其他基金

Airyscan-based Confocal Phase Tomography for high-resolution 3D imaging of cell growth- Administrative supplement
基于 Airyscan 的共焦相位断层扫描,用于细胞生长的高分辨率 3D 成像 - 行政补充
  • 批准号:
    9895090
  • 财政年份:
    2019
  • 资助金额:
    $ 17.52万
  • 项目类别:
High accuracy optical growth assay of 3D cellular systems
3D 细胞系统的高精度光学生长测定
  • 批准号:
    10094216
  • 财政年份:
    2019
  • 资助金额:
    $ 17.52万
  • 项目类别:
Label free imaging of blood smears and tissue biopsies
血涂片和组织活检的无标记成像
  • 批准号:
    8058667
  • 财政年份:
    2010
  • 资助金额:
    $ 17.52万
  • 项目类别:

相似海外基金

Optimizing blood biopsy in cancers with low mutation burden and high structural complexity
优化突变负荷低、结构复杂性高的癌症的血液活检
  • 批准号:
    10789700
  • 财政年份:
    2023
  • 资助金额:
    $ 17.52万
  • 项目类别:
L2M NSERC - A liquid biopsy blood test for breast cancer detection
L2M NSERC - 用于乳腺癌检测的液体活检血液测试
  • 批准号:
    576550-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 17.52万
  • 项目类别:
    Idea to Innovation
Liquid biopsy for Rhabdoid tumor by Exoxomal-microRNAs in blood and other body fluids
利用血液和其他体液中的 Exoxomal-microRNA 对横纹肌样瘤进行液体活检
  • 批准号:
    21K07778
  • 财政年份:
    2021
  • 资助金额:
    $ 17.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
  • 批准号:
    10634540
  • 财政年份:
    2021
  • 资助金额:
    $ 17.52万
  • 项目类别:
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
  • 批准号:
    10421266
  • 财政年份:
    2021
  • 资助金额:
    $ 17.52万
  • 项目类别:
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
  • 批准号:
    10844821
  • 财政年份:
    2021
  • 资助金额:
    $ 17.52万
  • 项目类别:
Implication search for peripheral blood circulation cancer cellsas a Liquid biopsy target
外周血循环癌细胞作为液体活检目标的意义研究
  • 批准号:
    21H03021
  • 财政年份:
    2021
  • 资助金额:
    $ 17.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Monitoring of residual and recurrence of cervical cancer after radiotherapy using blood liquid biopsy.
使用血液活检监测放疗后宫颈癌的残留和复发。
  • 批准号:
    20K08106
  • 财政年份:
    2020
  • 资助金额:
    $ 17.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a Novel Liquid Biopsy Technique for Colorectal Cancer Using MicroRNA Editing in Blood
利用血液中的 MicroRNA 编辑建立结直肠癌新型液体活检技术
  • 批准号:
    20K22848
  • 财政年份:
    2020
  • 资助金额:
    $ 17.52万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Prediction of colorectal cancer using liquid biopsy of the blood in surgically resected specimen
利用手术切除标本中血液的液体活检预测结直肠癌
  • 批准号:
    19K09127
  • 财政年份:
    2019
  • 资助金额:
    $ 17.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了